MON-554 Brain Metastases in Thyroid Cancer: Molecular Profile and Institutional Experience of a Single Tertiary Referral Center in the Era of Kinase Inhibitor Therapy

Background: Historical data suggests differentiated thyroid cancer (DTC) patients (pts) with brain metastases (mets) have overall survival (OS) of approximately 1 year; other reports refer median OS of 33months. Little is known about the mutation profile these pts. The TCGA indicates a median of 1 m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Endocr Soc
Main Authors: Agosto Salgado, Sarimar, Waguespack, Steven, Cote, Gilbert, Hess, Kenneth, Habra, Mouhammed, Jimenez, Camilo, Hu, Mimi, Sherman, Steven, Busaidy, Naifa, Dadu, Ramona, Tatsui, Claudio, McCutcheon, Ian, Grubbs, Elizabeth, Williams, Michelle, Shah, Komal, Cabanillas, Maria
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2019
Assuntos:
Thyroid
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6551022/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-MON-554
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados